Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The National HealthCare Corporation (NHC) SEC filings page provides access to the company’s regulatory disclosures as a NYSE American issuer. NHC’s common stock, with a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades under the symbol NHC. Through its affiliates, the company operates skilled nursing facilities, assisted living and independent living communities, behavioral health hospitals, homecare agencies, and hospice agencies, along with Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and management and accounting services to third party post-acute operators.
In its Form 8-K current reports, NHC discloses material events such as quarterly and annual earnings releases, dividend declarations, and significant lease and governance matters. For example, the company files 8-Ks to furnish earnings press releases for periods ended March 31, June 30, September 30, and December 31, and to announce quarterly common dividends. These filings often reference non-GAAP financial measures and include or incorporate reconciliations to GAAP results.
NHC’s 8-K filings also describe corporate governance and executive changes, including the appointment of new directors, committee assignments, and planned retirements of senior officers, as well as role changes for executives. Additional 8-Ks address lease arrangements, such as disclosures about a master lease with National Health Investors, Inc., letters alleging non-monetary non-compliance, cure periods, renewal options, and the potential for a material adverse impact on NHC’s financial position and results of operations if certain lease rights were lost.
On this page, users can review NHC’s SEC reports as they are made available through EDGAR and use AI-powered summaries to understand the key points in lengthy filings. These tools can help clarify topics such as segment reporting for inpatient services and home care hospice services, dividend practices, lease terms and disputes, and board and executive leadership changes, without replacing the full text of the official documents.
National HealthCare Corporation's tenant subsidiary has been notified by its landlord, National Health Investors, Inc., of alleged non-compliance with four non-monetary provisions of a Master Lease covering 35 facilities. The landlord's September 8, 2025 letter asserts a default and invoked the lease cure provisions, giving the tenant thirty days to cure or risk an Event of Default. The tenant disputes that the alleged matters constitute defaults, says it has proceeded with reasonable diligence to address any issues, and is negotiating with the landlord. The Master Lease currently runs through December 31, 2026, with two five-year renewal options and a right of first refusal to purchase leased properties; termination that removes renewal rights could have a material adverse effect on NHC's financial condition.
Stephen Flatt, CEO and director of National Healthcare Corp. (NHC), reported multiple equity transactions on 08/22/2025. He exercised stock options and acquired 4,000 shares in two option exercises at strike prices of $53.94 and $94.10, and the filings show withholding of 3,146 shares to cover exercise costs and taxes at an effective price of $114.82 per share. After these transactions, Flatt beneficially owns between 59,393 and 61,393 common shares depending on the line item referenced. The exercises relate to grants from the 2020 Omnibus Equity Incentive Plan dated March 8, 2023 and March 5, 2024.
J. Paul Abernathy, a director of National Healthcare Corp. (NHC), reported exercising stock options and a related share withholding on August 13, 2025. He exercised options granted May 6, 2021, resulting in the acquisition of 4,010 shares at an exercise price implied by the filing of $71.64 per share. Simultaneously, 2,639 shares were withheld by the company to satisfy the exercise price, leaving Mr. Abernathy with 39,033 shares beneficially owned after the transactions. The filing lists outstanding option grants from 2022, 2023, 2024 and 2025, each covering 7,500 options with exercise prices from $69.19 to $96.03 and standard exercisability/expiration schedules.
Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp. (NHC), exercised stock options and reported related share withholding. On 08/13/2025 Mr. McCreary exercised 4,000 options with an exercise price of $53.94, resulting in 4,000 shares acquired. To cover the exercise price and withholding taxes, the company withheld 2,737 shares at an implied price of $108.82. After these transactions, Mr. McCreary beneficially owned 9,716 shares of NHC common stock.
The exercised options were part of a grant from the 2020 Omnibus Equity Incentive Plan issued on 03/08/2023 and are exempt from Section 16(b) under Rule 16b-3(d). The Form 4 was signed 08/15/2025 and reports both non-derivative and derivative holdings, including existing options exercisable through 2030.
National HealthCare Corporation (NHC) filed a Form 8-K dated 8 Aug 2025 reporting Item 8.01 – Other Events. The filing states that on 7 Aug 2025 the company issued a press release announcing its quarterly common-stock dividend. The press release is furnished as Exhibit 99.1 and is incorporated by reference. No dividend amount, record date, or payment date is disclosed within the 8-K itself, and no additional financial data or material transactions are presented.
National Healthcare Corp. (NHC) Form 4 filing dated 06/26/2025 reports a Code G gift by Sr. VP Patient Services Vicki L. Dodson.
Dodson transferred 788 common shares at $0, lowering her direct holdings from 9,748.5455 to 8,960.5455 shares. No cash sale occurred.
The filing also lists existing equity incentives:
- 3,734 options exercisable at $53.94 (expire 03/08/2028)
- 12,000 options at $94.10 (expire 03/05/2029)
- 13,500 options at $90.62 (expire 02/24/2030)
No other changes to ownership or control were disclosed. Given the small share count and gift classification, investment impact is minimal.
FAQ
What is the current stock price of National Health (NHC)?
What is the market cap of National Health (NHC)?
